8BP9 image
Entry Detail
PDB ID:
8BP9
Keywords:
Title:
Structure of E. coli Class 2 L-asparaginase EcAIII, mutant M200W (crystal M200W#2)
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-11-16
Release Date:
2023-05-03
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.22
R-Value Work:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Isoaspartyl peptidase subunit alpha
Chain IDs:A (auth: AAA), C (auth: CCC)
Chain Length:178
Number of Molecules:2
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Description:Isoaspartyl peptidase subunit beta
Mutations:M200W
Chain IDs:B (auth: BBB), D (auth: DDD)
Chain Length:143
Number of Molecules:2
Biological Source:Escherichia coli K-12
Primary Citation
The effects of nature-inspired amino acid substitutions on structural and biochemical properties of the E. coli L-asparaginase EcAIII.
Protein Sci. 32 e4647 e4647 (2023)
PMID: 37095066 DOI: 10.1002/pro.4647

Abstact

The Escherichia coli enzyme EcAIII catalyzes the hydrolysis of L-Asn to L-Asp and ammonia. Using a nature-inspired mutagenesis approach, we designed and produced five new EcAIII variants (M200I, M200L, M200K, M200T, M200W). The modified proteins were characterized by spectroscopic and crystallographic methods. All new variants were enzymatically active, confirming that the applied mutagenesis procedure has been successful. The determined crystal structures revealed new conformational states of the EcAIII molecule carrying the M200W mutation and allowed a high-resolution observation of an acyl-enzyme intermediate with the M200L mutant. In addition, we performed structure prediction, substrate docking, and molecular dynamics simulations for 25 selected bacterial orthologs of EcAIII, to gain insights into how mutations at the M200 residue affect the active site and substrate binding mode. This comprehensive strategy, including both experimental and computational methods, can be used to guide further enzyme engineering and can be applied to the study of other proteins of medicinal or biotechnological importance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures